Chemotherapy-free regimens in frontline follicular lymphoma

被引：0
|
作者：
Batlevi, Connie Lee [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 139卷 / 15期
关键词：
LENALIDOMIDE;
D O I：
10.1182/blood.2021015120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lenalidomide and anti-CD20-based combinations have validated efficacy in treatment of follicular lymphoma in both the frontline and the relapsed settings. In this issue of Blood, Bachy et al(1) report the tolerability and efficacy of obinutuzumab and lenalidomide in the frontline therapy of follicular lymphoma.
引用
收藏
页码：2263 / 2264
页数：3
相关论文
共 50 条
  • [31] Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study
    Askeland, Georgina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (03) : 232 - 232
  • [32] Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study
    Askeland, Georgina
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (05) : 402 - 402
  • [33] Toward chemotherapy-free treatment of CLL
    Stilgenbauer, Stephan
    Mertens, Daniel
    BLOOD, 2011, 118 (13) : 3451 - 3452
  • [34] Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?
    Macapagal, Sharina C.
    Bennani, N. Nora
    BLOOD REVIEWS, 2023, 60
  • [35] The Emerging Use of Chemotherapy-Free Regimens in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Sawyers, Jacquelyn D.
    Jammal, Nadya J.
    Short, Nicholas J.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 68 - 75
  • [36] Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma
    Srour, Samer A.
    Lee, Hun J.
    Nomie, Krystle
    Ye, Haige
    Chen, Wendy
    Oriabure, Onyeka
    Romaguera, Jorge
    Wang, Michael L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (04) : 561 - 564
  • [37] Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy
    Ramos Perez, Jorge M.
    Patel, Keyur P.
    Loghavi, Sanam
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Jabbour, Elias
    Wierda, William
    Pierce, Sherry
    Brandt, Mark
    Kornblau, Steven
    Kadia, Tapan
    Daver, Naval
    DiNardo, Courtney D.
    Jain, Nitin
    Yilmaz, Musa
    Short, Nicholas
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Andreeff, Michael
    Konopleva, Marina
    Rivera, Daniel
    McCue, David
    Kantarjian, Hagop M.
    Ravandi, Farhad
    LEUKEMIA & LYMPHOMA, 2022, 63 (03) : 672 - 675
  • [38] Pretreated follicular Lymphoma New chemotherapy free Therapy Option
    Bischoff, Angelika
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (03) : 119 - 119
  • [39] Follicular Lymphoma Frontline Immuno-Chemotherapy: Survival Outcomes and Infection-Related Morbidity
    Djebbari, Faouzi
    Kaji, Furqaan
    Stanton, Louise
    Collins, Graham P.
    Eyre, Toby A.
    BLOOD, 2019, 134
  • [40] Targeted leukaemia therapy: a chemotherapy-free future?
    不详
    LANCET HAEMATOLOGY, 2021, 8 (01): : E1 - E1
12345